Skip to content
← Back to this collection

PUBLICATIONS · 37863088

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2023 Nov
First author
Pan J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2023 Nov;24(11):1163-1164. doi: 10.1016/S1470-2045(23)00517-X.
    note
    Source null
    related pmid
    37863087
    relationship
    Comment in

Authors and identifiers

  1. name
    Pan J
    type
    Author
  2. name
    Tang K
    type
    Author
  3. name
    Luo Y
    type
    Author
  4. name
    Seery S
    type
    Author
  5. name
    Tan Y
    type
    Author
  6. name
    Deng B
    type
    Author
  7. name
    Liu F
    type
    Author
  8. name
    Xu X
    type
    Author
  9. name
    Ling Z
    type
    Author
  10. name
    Song W
    type
    Author
  11. name
    Xu J
    type
    Author
  12. name
    Duan J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Pan J
    type
    Author
  2. name
    Tang K
    type
    Author
  3. name
    Luo Y
    type
    Author
  4. name
    Seery S
    type
    Author
  5. name
    Tan Y
    type
    Author
  6. name
    Deng B
    type
    Author
  7. name
    Liu F
    type
    Author
  8. name
    Xu X
    type
    Author
  9. name
    Ling Z
    type
    Author
  10. name
    Song W
    type
    Author
  11. name
    Xu J
    type
    Author
  12. name
    Duan J
    type
    Author
bibliography ids
  1. nci-bib-e39645642ad2686d12940f38
book metadata
content sha256
e400525f5e4ebd8ae571d4e2f89d6ffea294073c27bdb33dfd2fd96d8fbc103a
document type
citation
dois
  1. 10.1016/S1470-2045(23)00436-9
electronic publication date
display
2023 Oct 17
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:37863088
immutable id
pubmed:37863088@e400525f5e4ebd8ae571d4e2f89d6ffea294073c27bdb33dfd2fd96d8fbc103a
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1229-1241
volume
24
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2023 Nov;24(11):1163-1164. doi: 10.1016/S1470-2045(23)00517-X.
    note
    Source null
    related pmid
    37863087
    relationship
    Comment in
outcomes validated
false
pmid
37863088
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
650bd13d297be3ee00bc084c21d1c91ebce271b562fa78f2c2e700cea2c93a3c
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2023 Nov
precision
month
year
2023
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37863088/
title
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study.

Preserved source evidence · Not medical advice